The global epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis among patients with type 2 diabetes

Nonalcoholic fatty liver disease (NAFLD) now known as metabolic dysfunction associated steatotic liver disease (MASLD) is closely associated with type 2 diabetes (T2D). Our aim was to estimate the most recent global prevalence of NAFLD/MASLD, non-alcoholic steatohepatitis (NASH) now known as metabolic dysfunction associated steatohepatitis (MASH), advanced fibrosis, and mortality among patients with T2D.

https://www.cghjournal.org/article/S1542-3565(24)00287-8/fulltext?rss=yes

Source: Clinical Gastroenterology and Hepatology - March 21, 2024 Category: Gastroenterology Authors: Zobair M. Younossi, Pegah Golabi, Jillian Kallman Price, Soroor Owrangi, Nagashree Gundu-Rao, Romona Satchi, James Paik Tags: Systematic Reviews and Meta-analyses Source Type: research